{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:19:47Z","timestamp":1792549187311,"version":"4.5.0"},"reference-count":40,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"Khoo Teck Puat Hospital STAR Grant","award":["20201"],"award-info":[{"award-number":["20201"]}]},{"name":"Khoo Teck Puat Hospital STAR Grant","award":["23201"],"award-info":[{"award-number":["23201"]}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-000066"],"award-info":[{"award-number":["MOH-000066"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-000714-01"],"award-info":[{"award-number":["MOH-000714-01"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001327-02"],"award-info":[{"award-number":["MOH-001327-02"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>We sought to study the associations between plasma metabolites in the tryptophan-kynurenine pathway and the risk of progression to end-stage kidney disease (ESKD) in patients with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Plasma tryptophan, kynurenine, 3-hydroxykynurenine, kynurenic acid, and xanthurenic acid concentrations were measured in discovery (n = 1,915) and replication (n = 346) cohorts. External validation was performed in Chronic Renal Insufficiency Cohort (CRIC) participants with diabetes (n = 1,312). The primary outcome was a composite of incident ESKD (progression to estimated glomerular filtration rate [eGFR] &amp;lt;15 mL\/min\/1.73 m2, sustained dialysis, or renal death). The secondary outcome was annual eGFR decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>In the discovery cohort, tryptophan was inversely associated with risk for ESKD, and kynurenine-to-tryptophan ratio (KTR) was positively associated with risk for ESKD after adjustment for clinical risk factors, including baseline eGFR and albuminuria (adjusted hazard ratios [HRs] 0.62 [95% CI 0.51, 0.75] and 1.48 [1.20, 1.84] per 1 SD). High levels of kynurenic acid and xanthurenic acid were associated with low risks of ESKD (0.74 [0.60, 0.91] and 0.74 [0.60, 0.91]). Consistently, high levels of tryptophan, kynurenic acid, and xanthurenic acid were independently associated with a slower eGFR decline, while a high KTR was predictive of a faster eGFR decline. Similar outcomes were obtained in the replication cohort. Furthermore, the inverse association between kynurenic acid and risk of ESKD was externally validated in CRIC participants with diabetes (adjusted HR 0.78 [0.65, 0.93]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Accelerated catabolism of tryptophan in the kynurenine pathway may be involved in progressive loss of kidney function. However, shunting the kynurenine pathway toward the kynurenic acid branch may potentially slow renal progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc23-1147","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T11:31:34Z","timestamp":1696505494000},"page":"2223-2231","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":52,"title":["Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes"],"prefix":"10.2337","volume":"46","author":[{"given":"Jian-Jun","family":"Liu","sequence":"first","affiliation":[{"name":"1Clinical Research Unit, Khoo Teck Puat Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Ching","sequence":"additional","affiliation":[{"name":"2Duke-NUS Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Ning","family":"Wee","sequence":"additional","affiliation":[{"name":"2Duke-NUS Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Liu","sequence":"additional","affiliation":[{"name":"1Clinical Research Unit, Khoo Teck Puat Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resham L.","family":"Gurung","sequence":"additional","affiliation":[{"name":"1Clinical Research Unit, Khoo Teck Puat Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus","family":"Lee","sequence":"additional","affiliation":[{"name":"1Clinical Research Unit, Khoo Teck Puat Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiamunaa","family":"M.","sequence":"additional","affiliation":[{"name":"1Clinical Research Unit, Khoo Teck Puat Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Zheng","sequence":"additional","affiliation":[{"name":"1Clinical Research Unit, Khoo Teck Puat Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lye Siang","family":"Lee","sequence":"additional","affiliation":[{"name":"2Duke-NUS Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keven","family":"Ang","sequence":"additional","affiliation":[{"name":"1Clinical Research Unit, Khoo Teck Puat Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Ming","family":"Shao","sequence":"additional","affiliation":[{"name":"1Clinical Research Unit, Khoo Teck Puat Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Kovalik","sequence":"additional","affiliation":[{"name":"2Duke-NUS Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tavintharan","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"3Diabetes Center, Admiralty Medical Center, Khoo Teck Puat Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Fang","family":"Sum","sequence":"additional","affiliation":[{"name":"3Diabetes Center, Admiralty Medical Center, Khoo Teck Puat Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sharma","sequence":"additional","affiliation":[{"name":"4Center for Precision Medicine, The University of Texas Health, San Antonio, TX"},{"name":"5Division of Nephrology, Department of Medicine, The University of Texas Health, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan R.","family":"Kestenbaum","sequence":"additional","affiliation":[{"name":"6Kidney Research Institute, Seattle, WA"},{"name":"7Division of Nephrology, Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3361-7512","authenticated-orcid":false,"given":"Su Chi","family":"Lim","sequence":"additional","affiliation":[{"name":"3Diabetes Center, Admiralty Medical Center, Khoo Teck Puat Hospital, Singapore"},{"name":"8Saw Swee Hock School of Public Heath, National University of Singapore, Singapore"},{"name":"9Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"2023112719540556300_B1","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2023112719540556300_B2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc20-1913","article-title":"Worldwide epidemiology of diabetes-related end-stage renal disease, 2000-2015","volume":"44","author":"Cheng","year":"2021","journal-title":"Diabetes Care"},{"key":"2023112719540556300_B3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00125-018-4557-7","article-title":"Epidemiology of diabetes and diabetic complications in China","volume":"61","author":"Ma","year":"2018","journal-title":"Diabetologia"},{"key":"2023112719540556300_B4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"2023112719540556300_B5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/ajh\/hpy073","article-title":"The orphan receptor GPR35 contributes to angiotensin II-Induced hypertension and cardiac dysfunction in mice","volume":"31","author":"Divorty","year":"2018","journal-title":"Am J Hypertens"},{"key":"2023112719540556300_B6","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1111\/febs.16086","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme","volume":"289","author":"Pallotta","year":"2022","journal-title":"FEBS J"},{"key":"2023112719540556300_B7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/joim.13142","article-title":"Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans","volume":"289","author":"Baumgartner","year":"2021","journal-title":"J Intern Med"},{"key":"2023112719540556300_B8","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/ijc.32555","article-title":"Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)","volume":"146","author":"Huang","year":"2020","journal-title":"Int J Cancer"},{"key":"2023112719540556300_B9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"2023112719540556300_B10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1159\/000519811","article-title":"The Kynurenine pathway in acute kidney injury and chronic kidney disease","volume":"52","author":"Wee","year":"2021","journal-title":"Am J Nephrol"},{"key":"2023112719540556300_B11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/biomedicines8070222","article-title":"Amino acid metabolites associated with chronic kidney disease: an eight-year follow-up Korean epidemiology study","volume":"8","author":"Lee","year":"2020","journal-title":"Biomedicines"},{"key":"2023112719540556300_B12","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/ndt\/gft217","article-title":"Metabolites associate with kidney function decline and incident chronic kidney disease in the general population","volume":"28","author":"Goek","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2023112719540556300_B13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jc.2014-3855","article-title":"Elevation of a novel angiogenic factor, leucine-rich-\u03b12-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes","volume":"100","author":"Pek","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2023112719540556300_B14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/dc19-1295","article-title":"Association of urine haptoglobin with risk of all-cause and cause-specific mortality in individuals with type 2 diabetes: a transethnic collaborative work","volume":"43","author":"Liu","year":"2020","journal-title":"Diabetes Care"},{"key":"2023112719540556300_B15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023112719540556300_B16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1681\/ASN.2019080811","article-title":"Kidney clearance of secretory solutes is associated with progression of CKD: the CRIC study","volume":"31","author":"Chen","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2023112719540556300_B17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","article-title":"Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in Collaboration with the US Food and Drug Administration and European Medicines Agency","volume":"75","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2023112719540556300_B18","doi-asserted-by":"crossref","first-page":"F565","DOI":"10.1152\/ajprenal.2000.279.3.F565","article-title":"Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency","volume":"279","author":"Saito","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"2023112719540556300_B19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ki.2015.199","article-title":"Biomarkers of rapid chronic kidney disease progression in type 2 diabetes","volume":"88","author":"Looker","year":"2015","journal-title":"Kidney Int"},{"key":"2023112719540556300_B20","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/ki.2013.497","article-title":"Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study","volume":"85","author":"Niewczas","year":"2014","journal-title":"Kidney Int"},{"key":"2023112719540556300_B21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"2023112719540556300_B22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int"},{"key":"2023112719540556300_B23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41591-019-0415-5","article-title":"A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes","volume":"25","author":"Niewczas","year":"2019","journal-title":"Nat Med"},{"key":"2023112719540556300_B24","doi-asserted-by":"crossref","first-page":"686412","DOI":"10.3389\/fmolb.2021.686412","article-title":"NAD+ metabolism, metabolic stress, and infection","volume":"8","author":"Groth","year":"2021","journal-title":"Front Mol Biosci"},{"key":"2023112719540556300_B25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.2009.03902.x","article-title":"Inhibition of indoleamine 2, 3-dioxygenase-mediated tryptophan catabolism accelerates crescentic glomerulonephritis","volume":"156","author":"Hou","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2023112719540556300_B26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11255-019-02365-1","article-title":"The therapeutic effect of dendritic cells expressing indoleamine 2,3-dioxygenase (IDO) on an IgA nephropathy mouse model","volume":"52","author":"Liu","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"2023112719540556300_B27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000515041","article-title":"Indoleamine-2,3-dioxygenase activates Wnt\/\u03b2-catenin inducing kidney fibrosis after acute kidney injury","volume":"67","author":"Pan","year":"2021","journal-title":"Gerontology"},{"key":"2023112719540556300_B28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","article-title":"On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress","volume":"33","author":"Lugo-Huitr\u00f3n","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"2023112719540556300_B29","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3389\/fimmu.2017.01957","article-title":"Kynurenic acid: the Janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions","volume":"8","author":"Wirthgen","year":"2018","journal-title":"Front Immunol"},{"key":"2023112719540556300_B30","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.cell.2016.02.006","article-title":"EGLN1 inhibition and rerouting of \u03b1-ketoglutarate suffice for remote ischemic protection","volume":"164","author":"Olenchock","year":"2016","journal-title":"Cell"},{"key":"2023112719540556300_B31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"},{"key":"2023112719540556300_B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0210-x","article-title":"Kynurenine 3-monooxygenase is a critical regulator of renal ischemia-reperfusion injury","volume":"51","author":"Zheng","year":"2019","journal-title":"Exp Mol Med"},{"key":"2023112719540556300_B33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2014.09.020","article-title":"Effects of systemic administration of kynurenic acid and glycine on renal haemodynamics and excretion in normotensive and spontaneously hypertensive rats","volume":"743","author":"B\u0105dzy\u0144ska","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"2023112719540556300_B34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3177\/jnsv.47.306","article-title":"Xanthurenic acid inhibits metal ion-induced lipid peroxidation and protects NADP-isocitrate dehydrogenase from oxidative inactivation","volume":"47","author":"Murakami","year":"2001","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"2023112719540556300_B35","doi-asserted-by":"crossref","first-page":"17873","DOI":"10.1073\/pnas.0705553104","article-title":"Identification of xanthurenic acid 8-O-beta-D-glucoside and xanthurenic acid 8-O-sulfate as human natriuretic hormones","volume":"104","author":"Cain","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023112719540556300_B36","doi-asserted-by":"crossref","first-page":"e00155","DOI":"10.1002\/phy2.155","article-title":"Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-O-\u03b2-D-glucoside in rats","volume":"1","author":"Hoffman","year":"2013","journal-title":"Physiol Rep"},{"key":"2023112719540556300_B37","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1681\/ASN.2013020126","article-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","volume":"24","author":"Sharma","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2023112719540556300_B38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.yexmp.2009.02.002","article-title":"Effects of kynurenine metabolites on mesangial cell proliferation and gene expression","volume":"87","author":"Yoshimura","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"2023112719540556300_B39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.2092","article-title":"Kynurenine is an endothelium-derived relaxing factor produced during inflammation","volume":"16","author":"Wang","year":"2010","journal-title":"Nat Med"},{"key":"2023112719540556300_B40","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1681\/ASN.2012101006","article-title":"A combined epidemiologic and metabolomic approach improves CKD prediction","volume":"24","author":"Rhee","year":"2013","journal-title":"J Am Soc Nephrol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/46\/12\/2223\/739481\/dc231147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/46\/12\/2223\/739481\/dc231147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T14:54:34Z","timestamp":1701096874000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/46\/12\/2223\/153677\/Plasma-Tryptophan-Kynurenine-Pathway-Metabolites"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,10,5]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc23-1147","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}